Yaprak Seçil

Yaprak Seçil

Auto-generated profile, based on publicly available information

Yaprak Seçil

İZMİR KATİP ÇELEBİ ÜNİVERSİTESİ, TIP FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2025 in Kastamonu Medical Journal
Verified
Journal Article
Open access
PDF file
YSYaprak Seçil
Yaprak Seçil
FTFigen Tokuçoğlu
Figen Tokuçoğlu
TMTuğçe Mengi
Tuğçe Mengi
GDGözde Nur Doğan
Gözde Nur Doğan
TITülay Kurt İnCesu
Tülay Kurt İnCesu
YBYeşim Beckmann
Yeşim Beckmann
Organic solvents that are widely used in industrial production and abused amongst teenagers for recreational purposes may cause some neurological abnormalities including polyneuropathy. Poorly ventilated working environments and working without protective garments are the most common reasons of intoxication. N-hexane toxicity often causes sensorimotor mixed type demyelinating neuropathy, but axonal degeneration is not rare. We report five cases that had mainly axonal motor polyneuropathy due to n-hexane containing glue usage, with clinical and electrophysiological data. Clinical and electrophysiological examinations revealed predominantly motor findings. One patient had delayed P100 potential, two had abnormal conduction in fasciculus gracilis. “Coasting” phenomenon was observed in one patient. Neuropathy due to toxic agents is an important public health problem. Working place conditions must be strictly controlled if toxic materials are present. Patients who had electromyography compatible with polyneuropathy should be questioned for toxic exposure. Asymptomatic workers should also be examined. Patients should be followed for the possibility of “coasting” effect.

1 May 2008 in Clinical Neurophysiology
Verified
Journal Article
Closed access
FTFigen Tokucoglu
Figen Tokucoglu
YSYaprak Secil
Yaprak Secil
CACandan Aksit
Candan Aksit

30 December 2014 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
NBNazlı Gamze Bulbul
Nazlı Gamze Bulbul
YSYaprak Seçil
Yaprak Seçil
YBYesim Beckmann
Yesim Beckmann
TITülay Kurt Incesu
Tülay Kurt Incesu
GAGalip Akhan
Galip Akhan
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening clinical manifestation induced by neuroleptic medication. Although NMS is regarded as a psychiatric diagnosis, its treatment requires a systematic approach and thus intensive care follow-up. In this paper, we report nine cases with NMS followed up in our Neurology Intensive Care Unit over the last three years

8 December 2025 in Ege Tıp Dergisi
Verified
Journal Article
Closed access
ŞAŞeyma Aykaç
Şeyma Aykaç
AAAbdullah Arı
Abdullah Arı
BDBirgül Dere
Birgül Dere
YSYaprak Seçil
Yaprak Seçil
NYNur Yuceyar
Nur Yuceyar
Chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) are distinct autoimmune neuromuscular disorders that rarely coexist. We present a 52-year-old man with stable CIDP who developed progressive lower limb weakness and facial involvement. Electrophysiological studies revealed neuromuscular junction dysfunction, and elevated acetylcholine receptor antibodies confirmed MG. Treatment with pyridostigmine, intravenous immunoglobulin, and rituximab resulted in clinical stabilization. This case shows the importance of considering overlapping autoimmune disorders in CIDP patients with new or atypical symptoms. Early recognition using electrophysiological and serological tests is important for accurate diagnosis and effective management of coexisting CIDP and MG.

1 June 2014 in Clinical Neurophysiology
Verified
Journal Article
Closed access
YSY. Seçil
Y. Seçil
AÇA. Çakır
A. Çakır
YBY. Beckmann
Y. Beckmann
TIT. Kurt Incesu
T. Kurt Incesu
ŮAŮ. Arıcı
Ů. Arıcı
CEC. Ertekin
C. Ertekin

1 June 2014 in Clinical Neurophysiology
Verified
Journal Article
Closed access
TIT. Kurz Inescu
T. Kurz Inescu
FTF. Tokucoglu
F. Tokucoglu
YSY. Secil
Y. Secil
YBY. Beckmann
Y. Beckmann
GDG.N. Dogan
G.N. Dogan